Skip to content
HowShorted

Protara Therapeutics, Inc. short interest in 2026

In 2026, Protara Therapeutics, Inc.'s disclosed short interest ran from 6.54% of shares outstanding on 15 Jan 2026 to 7.47% on 15 Sep 2026, a change of +0.93 percentage points. The year's high was 12.69% on 27 Feb 2026 and its low 6.54% on 15 Jan 2026, averaging 8.96% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 12.36 days on 31 Aug 2026. Full history: Protara Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Protara Therapeutics, Inc. in 2026

2026 in figures

Start of year
6.54% (15 Jan 2026)
End of year
7.47% (15 Sep 2026)
Change
+0.93 pp
High
12.69% (27 Feb 2026)
Low
6.54% (15 Jan 2026)
Average
8.96%
Highest days to cover
12.36 (31 Aug 2026)
SEC filings marked
6

Every report in 2026

Protara Therapeutics, Inc. short interest in 2026
SettlementShort interestDays to coverFilings since previous
15 Jan 20266.54%2.06
30 Jan 20267.34%2.34
13 Feb 20268.57%6.15
27 Feb 202612.69%3.08
13 Mar 202611.83%6.1910-K filed, results (8-K)
31 Mar 202610.26%6.14
15 Apr 202610.62%11.15
30 Apr 202611.09%9.57
15 May 20266.91%5.6110-Q filed, results (8-K)
29 May 202610.89%6.17
15 Jun 20268.26%6.55
30 Jun 20268.02%5.12
15 Jul 20268.40%6.72
31 Jul 20268.31%11.47
14 Aug 20267.68%12.0310-Q filed, results (8-K)
31 Aug 20267.50%12.36
15 Sep 20267.47%10.34

See also: Protara Therapeutics, Inc.'s full history · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.